Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
J Asthma ; 61(4): 368-376, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37930803

RESUMEN

BACKGROUND: The association of asthma and metabolic syndrome (MetS) among adolescents and young adults (AYAs) remains unclear, as well as the role of obesity in this relationship. METHODS: AYAs aged 12-25 years who participated in the 2011-2020 National Health and Nutrition Examination Survey were included in this cross-sectional analysis. The moderating effect of obesity (age- and sex-adjusted body mass index ≥ 95th%ile for adolescents or ≥ 30 kg/m2 for adults) on asthma and MetS were evaluated in four groups: 1) both asthma and obesity; 2) asthma and no obesity; 3) obesity and no asthma; and 4) healthy controls with no obesity/asthma. RESULTS: A total of 7,709 AYAs (53.9% aged 12-18 years, 51.1% males, and 54.4% non-Hispanic White) were included in this analysis. 3.6% (95% CI 2.8-4.3%) had obesity and asthma, 7.6% (95% CI 6.8-8.4%) had asthma and no obesity, 21.4% (95% CI 19.6-23.2%) had obesity and no asthma, and 67.4% (95% CI 65.4-69.4%) had neither obesity nor asthma. The estimated prevalence of MetS was greater among those with both obesity and asthma versus those with only asthma (4.5% [95% CI 1.7-7.3%] vs. 0.2% [95% CI 0-0.5%], p < 0.001). Compared to healthy controls, those with both obesity and asthma had ∼10 times higher odds of having MetS (aOR 10.5, 95% CI 3.9-28.1). CONCLUSIONS: Our results show the association between MetS and asthma is stronger in AYAs with BMI-defined obesity. Efforts to prevent and treat obesity may reduce MetS occurrence in AYAs with asthma.


Asunto(s)
Asma , Síndrome Metabólico , Masculino , Humanos , Adolescente , Adulto Joven , Femenino , Síndrome Metabólico/epidemiología , Encuestas Nutricionales , Estudios Transversales , Asma/epidemiología , Asma/complicaciones , Obesidad/epidemiología , Obesidad/complicaciones , Índice de Masa Corporal , Prevalencia
2.
Ann Am Thorac Soc ; 20(10): 1373-1388, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37772940

RESUMEN

Despite growing recognition of the need for increased diversity among students, trainees, and faculty in health care, the medical workforce still lacks adequate representation from groups historically underrepresented in medicine (URiM). The subspecialty field of pediatric pulmonology is no exception. Although there have been efforts to address issues of diversity, equity, and inclusion (DEI) in our own field, gaps persist. To address these gaps, the members of the Diversity, Equity, and Inclusion Advisory Group (DEI-AG) of the American Thoracic Society Pediatrics Assembly created and distributed a Needs Assessment Survey in the United States and Canada to better understand the racial and ethnic demographics of the pediatric pulmonary workforce and to learn more about successes, gaps, and opportunities to enhance how we recruit, train, and retain a diverse workforce. The DEI-AG leadership cochairs convened a workshop to review the findings of the DEI Needs Assessment Survey and to develop strategies to improve the recruitment and retention of URiM fellows and faculty. This Official ATS Workshop Report aims to identify barriers and opportunities for recruitment, training, and career development within the field of pediatric pulmonology. Additionally, we offer useful strategies and resources to improve the recruitment of URiM residents, the mentorship of trainees and junior faculty, and the career development of URiM faculty in academic centers. This Workshop Report is an important first deliverable by the DEI-AG. We hope that this work, originating from within the Pediatrics Assembly, will serve as a model for other Assemblies, disciplines across the ATS, and other fields in Pediatrics.

4.
Curr Opin Allergy Clin Immunol ; 23(2): 137-143, 2023 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-36821483

RESUMEN

PURPOSE OF REVIEW: E-cigarettes have been long purported to be a mechanism of harm reduction in current smokers. However, market expansion to adolescents has been aggressive, despite government interventions. Research examining the adverse effects of e-cigarettes in teens with asthma has been limited. We discuss the most recent data on the pulmonary manifestations of e-cigarettes use and exposure in adolescents with asthma. RECENT FINDINGS: Adolescents with asthma are more likely to be e-cigarette users than those without asthma and more likely to have asthma exacerbations. Increased pulmonary inflammatory cytokines have been seen in e-cigarette users and mouse models. Yet, providers are not confident in e-cigarette screening and counselling despite acknowledging adolescents are using e-cigarettes regularly. SUMMARY: Since the introduction of e-cigarettes into the United States market in 2007, adolescents use of these products has risen, even after a brief decline during the height of the COVID-19 pandemic. This review will describe the most recent studies on e-cigarette use trends, cytotoxicity of e-cigarette aerosol and associations with the diagnosis and symptoms of asthma. Knowledge gaps, advocacy efforts, evidence on e-cigarette cessation will be highlighted.


Asunto(s)
Asma , COVID-19 , Sistemas Electrónicos de Liberación de Nicotina , Animales , Ratones , Humanos , Estados Unidos , Pandemias , Pulmón
5.
Womens Health (Lond) ; 18: 17455057221101071, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35670414

RESUMEN

BACKGROUND: Caesarean section, a common obstetric surgical procedure, is a major predisposing factor for puerperal infections, requiring the need for antibiotic prophylaxis. Evidence suggests that single-dose antibiotic prophylaxis has comparable efficacy to multiple-dose antibiotic prophylaxis, but with a lower cost and risk of antibiotic resistance. However, single-dose antibiotic prophylaxis after caesarean section is not generally used in many centres in sub-Saharan Africa. OBJECTIVE: This study aimed to compare the effectiveness of single- versus multiple-dose antibiotic prophylaxis to prevent post-caesarean section infections. METHODOLOGY: This open-label, randomized controlled trial involved 162 consenting patients admitted for caesarean section (elective or emergency) at the Federal Medical Centre Keffi. They were distributed randomly into treatment arm A or B. Subjects in both arms received intravenous ceftriaxone (1 g) and metronidazole (500 mg) 30-60 min before incision; subjects in arm B received additional parenteral doses for 48 h and then cefuroxime 500 mg tablets every 12 h and metronidazole 400 mg tablets every 8 h for 5 days. The patients were monitored for 2 weeks for evidence of wound infection, febrile morbidity and clinical endometritis. RESULT: There was no statistical difference in the incidence of wound infection (6.6% versus 7.4%; p = .882) and febrile morbidity (11.8% versus 11.1%, p = .807). However, clinical endometritis (0.0% versus 6.1%, p = .028) was statistically significant with none reported in the single-dose arm. CONCLUSION: Single-dose ceftriaxone and metronidazole is as effective as multiple doses for antibiotic prophylaxis to prevent post-caesarean section infections. Adoption of this approach in low-risk patients would reduce the cost of prophylactic antibiotics, workload for staff and antibiotic resistance.


Asunto(s)
Endometritis , Infección Puerperal , Antibacterianos/uso terapéutico , Profilaxis Antibiótica/métodos , Ceftriaxona , Cesárea/efectos adversos , Endometritis/epidemiología , Endometritis/etiología , Endometritis/prevención & control , Femenino , Humanos , Metronidazol , Periodo Posparto , Embarazo , Infección Puerperal/tratamiento farmacológico , Infección Puerperal/etiología , Infección Puerperal/prevención & control , Infección de la Herida Quirúrgica/epidemiología , Infección de la Herida Quirúrgica/etiología , Infección de la Herida Quirúrgica/prevención & control
7.
Pediatrics ; 146(1)2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32393606

RESUMEN

BACKGROUND: In the United States in 2019, there was an outbreak of electronic cigarette, or vaping, product use-associated lung injury (EVALI). The manifestations of EVALI in adolescents are not well characterized. We describe the diagnosis, evaluation, and management of EVALI in adolescents hospitalized at a tertiary care, university-affiliated children's hospital. METHODS: A multidisciplinary committee developed an EVALI algorithm on the basis of guidelines from the Centers for Disease Control and Prevention. A retrospective chart review was conducted on patients diagnosed with EVALI. Descriptive analyses included sociodemographic characteristics, clinical presentation, laboratory and imaging results, pulmonary function testing, oxygen requirements, and clinic follow-up. RESULTS: Thirteen hospitalized adolescents were diagnosed with confirmed or probable EVALI. The majority were female (54%) with a mean age of 15.9 years. Sixty-nine percent of patients presented with respiratory symptoms, whereas gastrointestinal symptoms were prominent in 85% of patients. Vaping Δ-9-tetrahydrocannabinol was reported in 92% of patients, and vaping nicotine was reported in 62% of patients. All had bilateral ground-glass opacities on the chest computed tomography (CT) scan. Treatment with glucocorticoids led to clinical improvement in 11 of 12 patients. Treatment with glucocorticoids led to improvement in both forced expiratory volume in 1 second and forced vital capacity (P < .05). Four patients required home oxygen on the basis of 6-minute walk test results. CONCLUSIONS: Diagnosis of EVALI should be suspected on the basis of vaping history and clinical presentation. Glucocorticoid treatment led to an improvement in symptoms and lung function. The 6-minute walk test may help determine oxygen needs at discharge.


Asunto(s)
Sistemas Electrónicos de Liberación de Nicotina , Lesión Pulmonar/epidemiología , Lesión Pulmonar/etiología , Vapeo/efectos adversos , Vapeo/epidemiología , Adolescente , Femenino , Humanos , Lesión Pulmonar/diagnóstico , Lesión Pulmonar/terapia , Masculino , Estudios Retrospectivos , Estados Unidos/epidemiología
8.
J Pediatr Health Care ; 31(1): 111-121, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-27321678

RESUMEN

INTRODUCTION: In children requiring long-term mechanical ventilation (LTMV), insufficient admission charting can lead to adverse events. Our purpose in this study was to create and evaluate a structured documentation tool of home LTMV settings to improve communication, documentation, and patient safety. METHOD: This study used a pretest-posttest survey of pulmonary unit nurses' satisfaction with the tool and perceptions of patient safety, chart reviews of documentation compliance, and reports of education session attendance. Mann-Whitney U and Fisher exact tests, category analyses, and descriptive statistics were applied. RESULTS: Nurses' reports of positive communication of LTMV settings increased from 54.5% to 100% (p = .002), overall satisfaction with associated documentation increased (p < .001), and witnessed related adverse events decreased from 50% to 18.75%. Nurse compliance for education attendance and documentation was 97.4% and 97.3%, respectively. DISCUSSION: Structured admission charting of LTMV settings should be continued and yielded improvements in pulmonary unit nurses' perceptions of communication, patient safety, and documentation compliance.


Asunto(s)
Competencia Clínica/estadística & datos numéricos , Cuidados Críticos , Documentación/estadística & datos numéricos , Servicios de Atención de Salud a Domicilio , Profesionales de Enfermería Pediátrica , Mejoramiento de la Calidad , Ventiladores Mecánicos , Actitud del Personal de Salud , Lista de Verificación , Niño , Práctica Clínica Basada en la Evidencia , Servicios de Atención de Salud a Domicilio/estadística & datos numéricos , Humanos , Educación del Paciente como Asunto , Proyectos Piloto , Texas
9.
J Clin Microbiol ; 52(8): 3124-6, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24899028

RESUMEN

Lactobacilli are low-virulence, commensal organisms of the gastrointestinal and genitourinary tracts and are commonly used as "probiotic supplements." Herein, we describe an episode of respiratory syncytial virus (RSV) bronchiolitis with bacterial superinfection secondary to administration of Lactobacillus rhamnosus in an 11-month-old female with trisomy 21.


Asunto(s)
Infecciones Bacterianas/diagnóstico , Síndrome de Down/complicaciones , Lacticaseibacillus rhamnosus/aislamiento & purificación , Neumonía por Aspiración/diagnóstico , Neumonía por Aspiración/microbiología , Probióticos/administración & dosificación , Infecciones por Virus Sincitial Respiratorio/diagnóstico , Infecciones Bacterianas/microbiología , Infecciones Bacterianas/patología , Femenino , Humanos , Lactante , Infecciones por Virus Sincitial Respiratorio/complicaciones , Infecciones por Virus Sincitial Respiratorio/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA